Skip to content

Accenture

US · ACN #182 by market cap Listed 1970
254.56 -6.38 -2.45%
Live - 5344 symbols - heartbeat 6s ago · 2026-11-03 22:27

Recent news

  • Rating change
    Goldman Sachs Maintains Accenture(ACN.US) With Buy Rating, Maintains Target Price $260
    \u5e02\u573a\u8d44\u8baf · 2026/10/5
  • Rating change
    SIG Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $230
    \u5e02\u573a\u8d44\u8baf · 2026/10/15
  • Rating change
    BMO Capital Maintains Accenture(ACN.US) With Hold Rating, Maintains Target Price $235
    \u5e02\u573a\u8d44\u8baf · 2026/10/15
  • Company notice
    DreamArts: ARISE analytics, a joint venture between KDDI and Accenture, has adopted SmartDB as its company-wide workflow platform.
    JPX · 2026/2/18
  • Accenture Stock Gets Downgraded as the Good News May Already Be Priced In -- Barrons.com
    Barron's · 2026/10/21
  • A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $230 to $278
    \u5e02\u573a\u8d44\u8baf · 2026/10/16
  • Company notice
    Serendip Holdings: Accenture has acquired the "Quick Series" business—strengthening support for manufacturing DX and smart factory transformation.
    JPX · 2026/7/6
  • Morgan Stanley: Accenture (ACN.US) pursues 'investment for growth,' with AI return replicability yet to be verified; maintains 'Equal-weight' rating.
    Zhitong Finance · 2026/10/15
  • Rating change
    Analysts Have Conflicting Sentiments on These Technology Companies: Life360, Inc. (LIF), Accenture (ACN) and CCC Intelligent Solutions Holdings (CCC)
    TipRanks · 2026/10/13
  • Rating change
    Mizuho Securities Maintains Accenture(ACN.US) With Buy Rating, Raises Target Price to $241
    \u5e02\u573a\u8d44\u8baf · 2026/10/6
  • RBC Capital Maintains Accenture(ACN.US) With Buy Rating, Maintains Target Price $240
    \u5e02\u573a\u8d44\u8baf · 2026/10/15
  • Company notice
    Accenture | 4: Statement of changes in beneficial ownership of securities-Director Jope Alan C.
    SEC · 2026/5/19
  • Company notice
    Accenture | 4: Statement of changes in beneficial ownership of securities-Director Jope Alan C.
    SEC · 2026/2/18
  • Rating change
    Morgan Stanley Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $175
    \u5e02\u573a\u8d44\u8baf · 2026/9/29
  • Rating change
    DBS Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $216
    \u5e02\u573a\u8d44\u8baf · 2026/10/12
  • Company notice
    Accenture | 4: Statement of changes in beneficial ownership of securities-Director Jope Alan C.
    SEC · 2026/2/10
  • Baird Downgrades Accenture(ACN.US) to Hold Rating, Raises Target Price to $252
    \u5e02\u573a\u8d44\u8baf · 2026/10/21
  • Rating change
    A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $220 to $245
    \u5e02\u573a\u8d44\u8baf · 2026/10/3
  • Rating change
    A Quick Look at Today's Ratings for Accenture(ACN.US), With a Forecast Between $190 to $260
    \u5e02\u573a\u8d44\u8baf · 2026/10/2
  • Rating change
    UBS Maintains Accenture(ACN.US) With Buy Rating, Maintains Target Price $275
    \u5e02\u573a\u8d44\u8baf · 2026/10/13
  • Rating change
    Guggenheim Downgrades Accenture(ACN.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • Rating change
    DBS Maintains Accenture(ACN.US) With Hold Rating, Cuts Target Price to $185
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • Rating change
    BMO Capital Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $200
    \u5e02\u573a\u8d44\u8baf · 2026/9/23
  • Rating change
    Jefferies Maintains Accenture(ACN.US) With Hold Rating, Raises Target Price to $190
    \u5e02\u573a\u8d44\u8baf · 2026/9/22
  • Rating change
    Wolfe Research Maintains Accenture(ACN.US) With Buy Rating, Cuts Target Price to $215
    \u5e02\u573a\u8d44\u8baf · 2026/8/25

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-03 22:27:32 · For reference only, not investment advice and not tailored to your situation.

Accenture discussion 0 comments

Add a comment